Preliminary tests on living mice and human samples in the lab suggest that curbing the activity of USP25 using drugs currently under development to inhibit the protein for other reasons suggest it could be effective at tackling pancreatic cancer in people. Read more . . .
Scientists have hailed a breakthrough that could revolutionise the treatment of pancreatic cancer after identifying a key cause of the disease, according to a government-backed study. The researchers have discovered a protein, known as USP25, fuels the growth of pancreatic cancer tumour. They said the findings could also pave the way for new breast cancer treatments, although the work in that area is far less advanced.